Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
314930.KQ
Strong SellFallen FavouriteBiodyne Co., Ltd. · Healthcare · South Korea · $157M · Avg Vol: $163K/d
COMPANY DESCRIPTION
Biodyne Co., Ltd. develops and manufactures medical devices and diagnostic systems, specializing in liquid-based cytology (LBC) for early cancer detection. The company's proprietary 'blow technology' for cell transfer provides a significant competitive advantage by improving diagnostic accuracy over traditional methods. Biodyne operates as a high-growth niche player with global licensing agreements with major multinational healthcare firms.
FINANCIAL SUMMARY (KRW)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.2B | 4.1B | 5.3B | 7.0B | -16.8% | 5.7B | 11.6B | 19.1B | 64.9% |
| EPS (KRW) | 37.80 | -6.60 | 0.37 | 29.00 | -8.5% | 28.82 | — | — | — |
| Shares | 29.4M | 29.5M | 29.5M | 29.5M | +0.2% | 29.5M | — | — | — |
| Debt | 12.0M | 12.1M | 12.1M | 11.0M | -2.8% | 6.3M | — | — | — |
| Equity | 44.2B | 43.4B | 43.2B | 44.1B | -0.1% | — | — | — | — |
| Op CF | 2.6B | 405.0M | 877.4M | 830.3M | -31.5% | 1.2B | — | — | — |
| Inv CF | -1.4B | -1.7B | -5.9B | 7.4B | — | — | — | — | — |
| Fin CF | -10.2M | 192.5M | -203.9M | -9.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 314930.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 314930.KQ | Biodyne Co., Ltd.(you) | $157M | 9 | Strong Sell |
| 216080.KQ | JETEMA, Co., Ltd. | $130M | 12 | Strong Sell |
| 219750.KQ | BTB Korea Co.,Ltd | $95M | 3 | Strong Sell |
| 464490.KQ | QuadMedicine | $65M | 5 | Strong Sell |
| 099430.KQ | Bio Plus Co., Ltd | $156M | 39 | Hold |
| 039840.KQ | DIO Corporation | $104M | 50 | Hold |
| 145720.KS | Dentium CO., LTD | $240M | 54 | Hold |
| 489460.KQ | BIOBIJOU Co.,Ltd. | $126M | 64 | Hold |
| 303810.KQ | DK Life Science Co., Ltd. | $53M | 50 | Hold |
| 179290.KQ | M.I.TECH Co.,Ltd | $124M | 76 | Buy |
Peer medians: ROE -0.3% · P/E 16.1x · Gross margin 43.0%